{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:42:21Z","timestamp":1792197741562,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cystic fibrosis (CF) is a life-limiting disorder that is characterised by respiratory tract inflammation that is mediated by a range of microbial pathogens. Small colony variants (SCVs) of common respiratory pathogens are being increasingly recognised in CF. The aim of this systematic review is to investigate the prevalence of SCVs, clinical characteristics and health outcomes for patients with CF, and laboratory diagnostic features of SCVs compared to non-small colony variants (NCVs) for a range of Gram-positive and Gram-negative respiratory pathogens.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A literature search was conducted (PubMed, Web of Science, Embase and Scopus) in April 2020 to identify articles of interest. Data pertaining to demographic characteristics of participants, diagnostic criteria of SCVs, SCV prevalence and impact on lung function were extracted from included studies for analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-five of 673 studies were included in the systematic review. Individuals infected with SCVs of <jats:italic>Staphylococcus aureus<\/jats:italic> (<jats:italic>S. aureus<\/jats:italic>) were more likely to have had prior use of the broad-spectrum antibiotic trimethoprim sulfamethoxazole (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and the prevalence of SCVs in patients infected with <jats:italic>S. aureus<\/jats:italic> was estimated to be 19.3% (95% CI: 13.5% to 25.9%). Additionally, patients infected with SCVs of Gram-negative and Gram-positive pathogens were identified to have a lower forced expiratory volume in one second percentage predicted (-16.8, 95% CI: -23.2 to -10.4) than those infected by NCVs. Gram-positive SCVs were commonly described as small and non-haemolytic, grown on Mannitol salt or blood agar for 24\u00a0h at 35\u00b0C and confirmed using tube coagulase testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings of this systematic review demonstrate that SCVs of <jats:italic>S. aureus<\/jats:italic> have a high prevalence in the CF community, and that the occurrence of SCVs in Gram-positive and Gram-negative pathogens is linked to poorer respiratory function. Further investigation is necessary to determine the effect of infection by SCVs on the CF population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-023-02611-4","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T16:03:22Z","timestamp":1693584202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Harrigan","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Duplancic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"issue":"6","key":"2611_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/17476348.2016.1177460","volume":"10","author":"H Lund-Palau","year":"2016","unstructured":"Lund-Palau H, Turnbull AR, Bush A, Bardin E, Cameron L, Soren O, et al. Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches. Expert Rev Respir Med. 2016;10(6):685\u201397.","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"2611_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/thoraxjnl-2015-207588","volume":"71","author":"IJ Haq","year":"2016","unstructured":"Haq IJ, Gray MA, Garnett JP, Ward C, Brodlie M. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets. Thorax. 2016;71(3):284.","journal-title":"Thorax"},{"issue":"1","key":"2611_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1755-7682-1-24","volume":"1","author":"HDM Coutinho","year":"2008","unstructured":"Coutinho HDM, Falc\u00e3o-Silva VS, Gon\u00e7alves GF. Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int Arch Med. 2008;1(1):24.","journal-title":"Int Arch Med."},{"issue":"1","key":"2611_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65\u2013124.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"2611_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/MCP.0b013e32834b8c04","volume":"17","author":"AE Stenbit","year":"2011","unstructured":"Stenbit AE, Flume PA. Pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med. 2011;17(6):442\u20137.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"2611_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jcf.2009.10.005","volume":"9","author":"CR Hansen","year":"2010","unstructured":"Hansen CR, Pressler T, Nielsen KG, Jensen P\u00d8, Bjarnsholt T, H\u00f8iby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros. 2010;9(1):51\u20138.","journal-title":"J Cyst Fibros"},{"issue":"8","key":"2611_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ijmm.2010.08.003","volume":"300","author":"C Goerke","year":"2010","unstructured":"Goerke C, Wolz C. Adaptation of Staphylococcus aureus to the cystic fibrosis lung. Int J Med Microbiol. 2010;300(8):520\u20135.","journal-title":"Int J Med Microbiol"},{"issue":"6","key":"2611_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1469-0691.2009.02786.x","volume":"16","author":"B Martha","year":"2010","unstructured":"Martha B, Croisier D, Fanton A, Astruc K, Piroth L, Huet F, et al. Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect. 2010;16(6):617\u201323.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"2611_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrmicro1384","volume":"4","author":"RA Proctor","year":"2006","unstructured":"Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol. 2006;4(4):295\u2013305.","journal-title":"Nat Rev Microbiol"},{"key":"2611_CR10","doi-asserted-by":"publisher","first-page":"MBI.S25800","DOI":"10.4137\/MBI.S25800","volume":"8","author":"BE Johns","year":"2015","unstructured":"Johns BE, Purdy KJ, Tucker NP, Maddocks SE. Phenotypic and genotypic characteristics of small colony variants and their role in chronic infection. Microbiol Insights. 2015;8:MBI.S25800.","journal-title":"Microbiol Insights."},{"issue":"1","key":"2611_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/JCM.01510-06","volume":"45","author":"S Besier","year":"2007","unstructured":"Besier S, Smaczny C, von Mallinckrodt C, Krahl A, Ackermann H, Brade V, et al. Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol. 2007;45(1):168.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2611_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1469-0691.2011.03742.x","volume":"19","author":"S Yagci","year":"2013","unstructured":"Yagci S, Hascelik G, Dogru D, Ozcelik U, Sener B. Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients. Clin Microbiol Infect. 2013;19(1):77\u201384.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"2611_CR13","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12223-010-0089-3","volume":"55","author":"O Melter","year":"2010","unstructured":"Melter O, Radojevi\u010d B. Small colony variants of Staphylococcus aureus \u2014 review. Folia Microbiol. 2010;55(6):548\u201358.","journal-title":"Folia Microbiol"},{"issue":"12","key":"2611_CR14","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S2213-2600(19)30365-0","volume":"7","author":"DJ Wolter","year":"2019","unstructured":"Wolter DJ, Onchiri FM, Emerson J, Precit MR, Lee M, McNamara S, et al. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study. Lancet Respir Med. 2019;7(12):1027\u201338.","journal-title":"Lancet Respir Med"},{"key":"2611_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fcimb.2014.00099","volume":"4","author":"RA Proctor","year":"2014","unstructured":"Proctor RA, Proctor RA, Kriegeskorte A, Kriegeskorte A, Kahl BC, Kahl BC, et al. Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections. Front Cell Infect Microbiol. 2014;4:99.","journal-title":"Front Cell Infect Microbiol."},{"issue":"2","key":"2611_CR16","first-page":"235","volume":"38","author":"P Morelli","year":"2015","unstructured":"Morelli P, De Alessandri A, Manno G, Marchese A, Bassi M, Lobello R, et al. Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre. New Microbiol. 2015;38(2):235\u201343.","journal-title":"New Microbiol"},{"issue":"3","key":"2611_CR17","doi-asserted-by":"publisher","first-page":"e1000804-e","DOI":"10.1371\/journal.ppat.1000804","volume":"6","author":"JG Malone","year":"2010","unstructured":"Malone JG, Jaeger T, Spangler C, Ritz D, Spang A, Arrieumerlou C, et al. YfiBNR Mediates Cyclic di-GMP Dependent Small Colony Variant Formation and Persistence in Pseudomonas aeruginosa. PLoS Pathog. 2010;6(3):e1000804-e.","journal-title":"PLoS Pathog."},{"issue":"5","key":"2611_CR18","doi-asserted-by":"publisher","first-page":"e65018-e","DOI":"10.1371\/journal.pone.0065018","volume":"8","author":"G Mitchell","year":"2013","unstructured":"Mitchell G, Fug\u00e8re A, P\u00e9pinGaudreau K, Brouillette E, Frost EH, Cantin AM, et al. SigB Is a Dominant Regulator of Virulence in Staphylococcus aureus Small-Colony Variants. PLoS One. 2013;8(5):e65018-e.","journal-title":"PLoS One."},{"issue":"1","key":"2611_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1128\/JB.188.1.64-76.2006","volume":"188","author":"H Moisan","year":"2006","unstructured":"Moisan H, Brouillette E, Jacob CL, Langlois-B\u00e9gin P, Michaud S, Malouin F. Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol. 2006;188(1):64\u201376.","journal-title":"J Bacteriol"},{"issue":"2","key":"2611_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2217\/fmb.14.107","volume":"10","author":"TJ Evans","year":"2015","unstructured":"Evans TJ. Small colony variants of Pseudomonas aeruginosa in chronic bacterial infection of the lung in cystic fibrosis. Future Microbiol. 2015;10(2):231\u20139.","journal-title":"Future Microbiol"},{"issue":"4","key":"2611_CR21","doi-asserted-by":"publisher","first-page":"e1004870-e","DOI":"10.1371\/journal.ppat.1004870","volume":"11","author":"L Tuchscherr","year":"2015","unstructured":"Tuchscherr L, Bischoff M, Lattar SM, Noto Llana M, Pf\u00f6rtner H, Niemann S, et al. Sigma factor SigB is crucial to mediate staphylococcus aureus adaptation during chronic infections. PLoS Pathog. 2015;11(4):e1004870-e.","journal-title":"PLoS Pathog."},{"issue":"7","key":"2611_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1086\/656047","volume":"202","author":"L Tuchscherr","year":"2010","unstructured":"Tuchscherr L, Heitmann V, Hussain M, Viemann D, Roth J, von Eiff C, et al. Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis. 2010;202(7):1031\u201340.","journal-title":"J Infect Dis"},{"issue":"3","key":"2611_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/cid\/cit270","volume":"57","author":"DJ Wolter","year":"2013","unstructured":"Wolter DJ, Emerson JC, McNamara S, Buccat AM, Qin X, Cochrane E, et al. Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis. 2013;57(3):384\u201391.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2611_CR24","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1128\/JCM.00361-08","volume":"46","author":"M Schneider","year":"2008","unstructured":"Schneider M, M\u00fchlemann K, Droz S, Couzinet S, Casaulta C, Zimmerli S. Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 2008;46(5):1832\u20134.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2611_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00284-016-0994-z","volume":"72","author":"L Masoud-Landgraf","year":"2016","unstructured":"Masoud-Landgraf L, Zarfel G, Kaschnigg T, Friedl S, Feierl G, Wagner-Eibel U, et al. Analysis and characterization of staphylococcus aureus small colony variants isolated from cystic fibrosis patients in Austria. Curr Microbiol. 2016;72(5):606\u201311.","journal-title":"Curr Microbiol"},{"issue":"4","key":"2611_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10096-003-0901-y","volume":"22","author":"S H\u00e4u\u00dfler","year":"2003","unstructured":"H\u00e4u\u00dfler S, Lehmann C, Breselge C, Rohde M, Cla\u00dfen M, T\u00fcmmler B, et al. Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia Cepacia complex. E J Clin Microbiol Infect Dis. 2003;22(4):249\u201353.","journal-title":"E J Clin Microbiol Infect Dis"},{"issue":"1","key":"2611_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"key":"2611_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Review Interventions","author":"JPT Higgins","year":"2019","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic review interventions. 2nd ed. Chichester: Wiley; 2019.","edition":"2"},{"issue":"2","key":"2611_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1128\/JCM.01444-06","volume":"45","author":"SW Anderson","year":"2007","unstructured":"Anderson SW, Stapp JR, Burns JL, Qin X. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. J Clin Microbiol. 2007;45(2):529\u201335.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"2611_CR30","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1128\/AAC.01395-07","volume":"52","author":"S Besier","year":"2008","unstructured":"Besier S, Zander J, Kahl BC, Kraiczy P, Brade V, Wichelhaus TA. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2008;52(6):2183\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2611_CR31","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/ppul.23699","volume":"52","author":"R Carzino","year":"2017","unstructured":"Carzino R, Hart E, Sutton P, King L, Ranganathan S, on behalf of AC. Lack of small colony variants of Staphylococcus aureus from lower respiratory tract specimens. Pediatr Pulmonol. 2017;52(5):632\u20135.","journal-title":"Pediatr Pulmonol."},{"issue":"6","key":"2611_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/ppul.24730","volume":"55","author":"DC de Souza","year":"2020","unstructured":"de Souza DC, Cogo LL, Palmeiro JK, Dalla-Costa LM, de Oliveira Tomaz AP, Riedi CA, et al. Thymidine-auxotrophic Staphylococcus aureus small-colony variant bacteremia in a patient with cystic fibrosis. Pediatr Pulmonol. 2020;55(6):1388\u201393.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"2611_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jcf.2018.04.008","volume":"18","author":"M Dod\u00e9mont","year":"2019","unstructured":"Dod\u00e9mont M, Argud\u00edn MA, Willekens J, Vanderhelst E, Pierard D, Miendje Deyi VY, et al. Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: result of a Belgian national survey. J Cyst Fibros. 2019;18(1):86\u201393.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"2611_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1099\/jmm.0.05069-0","volume":"52","author":"S Haussler","year":"2003","unstructured":"Haussler S. Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. J Med Microbiol. 2003;52(4):295\u2013301.","journal-title":"J Med Microbiol"},{"issue":"11","key":"2611_CR35","doi-asserted-by":"publisher","first-page":"e0166220","DOI":"10.1371\/journal.pone.0166220","volume":"11","author":"S Junge","year":"2016","unstructured":"Junge S, G\u00f6rlich D, den Reijer M, Wiedemann B, T\u00fcmmler B, Ellemunter H, et al. Factors associated with worse lung function in cystic fibrosis patients with persistent Staphylococcus aureus. PLoS One. 2016;11(11):e0166220.","journal-title":"PLoS One"},{"issue":"4","key":"2611_CR36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1086\/515238","volume":"177","author":"B Kahl","year":"1998","unstructured":"Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E, et al. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis. 1998;177(4):1023\u20139.","journal-title":"J Infect Dis"},{"issue":"9","key":"2611_CR37","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1128\/JCM.41.9.4424-4427.2003","volume":"41","author":"BC Kahl","year":"2003","unstructured":"Kahl BC, Duebbers A, Lubritz G, Haeberle J, Koch HG, Ritzerfeld B, et al. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol. 2003;41(9):4424\u20137.","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2611_CR38","doi-asserted-by":"publisher","first-page":"e0204167-e","DOI":"10.1371\/journal.pone.0204167","volume":"13","author":"C Lozano","year":"2018","unstructured":"Lozano C, Azcona-Guti\u00e9rrez JM, Van Bambeke F, S\u00e1enz Y. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient. PLoS One. 2018;13(9):e0204167-e.","journal-title":"PLoS One"},{"issue":"3","key":"2611_CR39","first-page":"475","volume":"47","author":"N Pakasticali","year":"2016","unstructured":"Pakasticali N, Kaya G, Senel U, Kipritci O, Tamay Z, Guler N, et al. Prevalence, antibiotic and pulsed-field gel electrophoresis patterns of Staphylococcus aureus small-colony variants in cystic fibrosis patients. Southeast Asian J Trop Med Public Health. 2016;47(3):475\u201384.","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3","key":"2611_CR40","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1128\/AAC.02330-15","volume":"60","author":"MR Precit","year":"2016","unstructured":"Precit MR, Wolter DJ, Griffith A, Emerson J, Burns JL, Hoffman LR. Optimized in vitro antibiotic susceptibility testing method for small-colony variant Staphylococcus aureus. Antimicrob Agents Chemother. 2016;60(3):1725\u201335.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2611_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ijmm.2018.02.003","volume":"308","author":"M Schwerdt","year":"2018","unstructured":"Schwerdt M, Neumann C, Schwartbeck B, Kampmeier S, Herzog S, G\u00f6rlich D, et al. Staphylococcus aureus in the airways of cystic fibrosis patients - a retrospective long-term study. Int J Med Microbiol. 2018;308(6):631\u20139.","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"2611_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.diagmicrobio.2017.11.012","volume":"90","author":"N Suwantarat","year":"2018","unstructured":"Suwantarat N, Rubin M, Bryan L, Tekle T, Boyle MP, Carroll KC, et al. Frequency of small-colony variants and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in cystic fibrosis patients. Diagn Microbiol Infect Dis. 2018;90(4):296\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"2611_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1089\/mdr.2014.0276","volume":"21","author":"J Tkadlec","year":"2015","unstructured":"Tkadlec J, Va\u0159ekov\u00e1 E, Pant\u016f\u010dek R, Do\u0161ka\u0159 J, R\u016f\u017ei\u010dkov\u00e1 V, Botka T, et al. Characterization of Staphylococcus aureus strains isolated from Czech cystic fibrosis patients: high rate of ribosomal mutation conferring resistance to MLS(B) antibiotics as a result of long-term and low-dose azithromycin treatment. Microb Drug Resist. 2015;21(4):416\u201323.","journal-title":"Microb Drug Resist"},{"issue":"5","key":"2611_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/jac\/dkm037","volume":"59","author":"A Vergison","year":"2007","unstructured":"Vergison A, Denis O, Deplano A, Casimir G, Claeys G, DeBaets F, et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother. 2007;59(5):893\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2611_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","volume":"14","author":"AM Cantin","year":"2015","unstructured":"Cantin AM, Hartl D, Konstan MW, Chmiel JF. Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros. 2015;14(4):419\u201330.","journal-title":"J Cyst Fibros"},{"issue":"3","key":"2611_CR46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jcf.2016.01.004","volume":"15","author":"A Hector","year":"2016","unstructured":"Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, et al. Microbial colonization and lung function in adolescents with cystic fibrosis. J Cyst Fibros. 2016;15(3):340\u20139.","journal-title":"J Cyst Fibros"},{"key":"2611_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgar.2018.05.008","volume":"15","author":"T Sato","year":"2018","unstructured":"Sato T, Kawamura M, Furukawa E, Fujimura S. Screening method for trimethoprim\/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus. J Glob Antimicrob Resist. 2018;15:1\u20135.","journal-title":"J Glob Antimicrob Resist"},{"issue":"12","key":"2611_CR48","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1128\/AAC.00742-15","volume":"59","author":"A Kriegeskorte","year":"2015","unstructured":"Kriegeskorte A, Lor\u00e8 NI, Bragonzi A, Riva C, Kelkenberg M, Becker K, et al. Thymidine-dependent staphylococcus aureus small-colony variants are induced by Trimethoprim-Sulfamethoxazole (SXT) and have increased fitness during SXT challenge. Antimicrob Agents Chemother. 2015;59(12):7265\u201372.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2611_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/emmm.201000115","volume":"3","author":"L Tuchscherr","year":"2011","unstructured":"Tuchscherr L, Medina E, Hussain M, V\u00f6lker W, Heitmann V, Niemann S, et al. Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med. 2011;3(3):129\u201341.","journal-title":"EMBO Mol Med"},{"issue":"8","key":"2611_CR50","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ijmm.2010.08.002","volume":"300","author":"BC Kahl","year":"2010","unstructured":"Kahl BC. Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease. Int J Med Microbiol. 2010;300(8):514\u20139.","journal-title":"Int J Med Microbiol"},{"issue":"11","key":"2611_CR51","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974\u20138.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"2611_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jcf.2011.08.006","volume":"11","author":"E Vanderhelst","year":"2012","unstructured":"Vanderhelst E, De Meirleir L, Verbanck S, Pi\u00e9rard D, Vincken W, Malfroot A. Prevalence and impact on FEV1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with Cystic Fibrosis: A single-center, case control study of 165 patients. J Cyst Fibros. 2012;11(1):2\u20137.","journal-title":"J Cyst Fibros"},{"key":"2611_CR53","first-page":"55","volume":"20","author":"SN Harun","year":"2016","unstructured":"Harun SN, Wainwright C, Klein K, Hennig S. A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis. Paediatr Respir Rev. 2016;20:55\u201366.","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"2611_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcf.2013.09.004","volume":"13","author":"JL Burns","year":"2014","unstructured":"Burns JL, Rolain JM. Culture-based diagnostic microbiology in cystic fibrosis: Can we simplify the complexity? J Cyst Fibros. 2014;13(1):1\u20139.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"2611_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1128\/jcm.28.4.676-679.1990","volume":"28","author":"LM Baddour","year":"1990","unstructured":"Baddour LM, Barker LP, Christensen GD, Parisi JT, Simpson WA. Phenotypic variation of Staphylococcus epidermidis in infection of transvenous endocardial pacemaker electrodes. J Clin Microbiol. 1990;28(4):676\u20139.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2611_CR56","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1086\/520462","volume":"29","author":"C von Eiff","year":"1999","unstructured":"von Eiff C, Vaudaux P, Kahl BC, Lew D, Emler S, Schmidt A, et al. Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin Infect Dis. 1999;29(4):932\u20134.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2611_CR57","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00402-002-0435-2","volume":"122","author":"B Rolauffs","year":"2002","unstructured":"Rolauffs B, Bernhardt T, von Eiff C, Hart M, Bettin D. Osteopetrosis, femoral fracture, and chronic osteomyelitis caused by Staphylococcus aureus small colony variants (SCV) treated by girdlestone resection \u2013 6-year follow-up. Arch Orthop Trauma Surg. 2002;122(9):547\u201350.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"2611_CR58","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/1756-0500-5-374","volume":"5","author":"LN Churkina","year":"2012","unstructured":"Churkina LN, Bidnenko SI, Lopes dos Santos Santiago G, Vaneechoutte M, Avdeeva LV, Lutko OB, et al. Application of the antibiotic batumin for accurate and rapid identification of staphylococcal small colony variants. BMC Res Notes. 2012;5(1):374.","journal-title":"BMC Res Notes"},{"key":"2611_CR59","first-page":"3","volume":"42","author":"IM Balfour-Lynn","year":"2022","unstructured":"Balfour-Lynn IM, King JA. CFTR modulator therapies \u2013 effect on life expectancy in people with cystic fibrosis. Paediatr Respir Rev. 2022;42:3\u20138.","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"2611_CR60","doi-asserted-by":"publisher","first-page":"17066","DOI":"10.1038\/s41598-018-35151-7","volume":"8","author":"S Zhang","year":"2018","unstructured":"Zhang S, Shrestha CL, Kopp BT. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function. Sci Rep. 2018;8(1):17066\u2013110.","journal-title":"Sci Rep"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02611-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02611-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02611-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:05:32Z","timestamp":1700409932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02611-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2611"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02611-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"16 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}